Competition Doesn’t Slow Cancer Drug Price Increases

HEALTH NEWS Fact Checked Written by Bob Curley on November 20, 2017 New research shows the average price increase for cancer drugs has risen 37 percent over 12 years. Research costs and high demand are among the reasons. Cancer drug prices seem to defy the laws of economics. They steadily increase regardless of competition, a …

Refer to the original article of aBestFamily at : Competition Doesn’t Slow Cancer Drug Price Increases - abestfamily.com

Comments

Popular posts from this blog

Long-term test wrap-up: 2013 Cadillac ATS

How the big banks are making a mockery of a genuine attempt to reform financial services

What to do in Lisbon: Why the Portuguese capital is Europe's best summer city break